Trade Gilead ^GILD

GILEAD SCIENCES, INC. Reduces Stake in Arcellx Inc by 6,720,703 Shares

RNC Capital Management LLC Increases Stake in Gilead Sciences, Inc. $GILD

Morse Asset Management Inc Invests $1.22 Million in Gilead Sciences, Inc. $GILD

Use of Gilead's HIV prevention shot rises, but US insurance gaps remain - Yahoo News Canada

Gilead Sciences, Inc. $GILD Shares Acquired by M&T Bank Corp

Gilead Sciences, Inc. $GILD Shares Purchased by QRG Capital Management Inc. - Stock Observer

Alliance Wealth Advisors LLC UT Cuts Stake in Gilead Sciences, Inc. $GILD

Earnings Strength Moves Into Focus as the Busiest Week of Q1 Season Begins | Investing.com UK

Earnings Strength Moves Into Focus as the Busiest Week of Q1 Season Begins | Investing.com Canada

Gilead Sciences, Inc. $GILD Shares Bought by Triasima Portfolio Management inc.

Can You Sue A Drug Company For Not Inventing Faster?

Gilead Sciences, Inc. $GILD Shares Sold by Varma Mutual Pension Insurance Co - Stock Observer

Pinnacle Wealth Management Advisory Group LLC Cuts Stock Position in Gilead Sciences, Inc. $GILD - Stock Observer

Is Trial Failures And Gilead Pullback Altering The Investment Case For Arcus Biosciences (RCUS)?

Hussman Strategic Advisors Inc. Cuts Stake in Gilead Sciences, Inc. $GILD - Daily Political

Strs Ohio Reduces Stock Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Holdings Increased by Sigma Planning Corp

Assessing Gilead Sciences (GILD) Valuation As Long Term Returns Contrast With Recent Share Performance

GILD: Future Returns Will Hinge On Executing Oncology And ADC Acquisitions

Biopharma M&A Surge Expected in 2026 Amid Patent Expirations

Big Pharma M&A set for mega year as patent expiries drive deal urgency

Jennison Associates LLC Buys 741,044 Shares of Gilead Sciences, Inc. $GILD - Zolmax

Oppenheimer & Co. Inc. Cuts Position in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by New York State Teachers Retirement System

US Bancorp DE Has $105.44 Million Stock Position in Gilead Sciences, Inc. $GILD

Fifth Third Bancorp Increases Position in Gilead Sciences, Inc. $GILD

Danske Bank A S Sells 45,529 Shares of Gilead Sciences, Inc. $GILD

Keybank National Association OH Has $14.15 Million Stock Position in Gilead Sciences, Inc. $GILD - Zolmax

Gilead Sciences (NASDAQ:GILD) CEO Daniel Patrick O'day Sells 10,000 Shares - Zolmax

Is Gilead Sciences, Inc. (GILD) A Good Stock To Buy Now?

Gilead Sciences Annual Meeting: Directors, Pay Win Big; Pipeline Launches and Acquisitions Highlighted - Stock Observer

Gilead Sciences, Inc. $GILD Shares Sold by Verity Asset Management Inc.

Gilead Sciences, Inc. $GILD Position Trimmed by State of New Jersey Common Pension Fund D

FY2026 EPS Estimates for Gilead Sciences Reduced by Analyst

Is It Time To Revisit Gilead Sciences (GILD) After Recent Share Price Pullback

Gilead Sciences (NASDAQ:GILD) CEO Sells $1,291,600.00 in Stock

GILD: Gilead's New HIV Treatment Gains FDA Acceptance

How Investors May Respond To Kymera Therapeutics (KYMR) FDA Fast Track Win And Gilead Trial Expansion

Morgan Stanley Forecasts Strong Price Appreciation for Gilead Sciences (NASDAQ:GILD) Stock

Gilead Sciences, Inc. (NASDAQ:GILD) Given Consensus Rating of "Moderate Buy" by Analysts

Gilead Sciences (GILD) Closes $7.8B Arcellx Buyout - What Investors Need to Know

Gilead Sciences Completes Acquisition of Arcellx (ACLX)

Merck Broadens Growth Story With Heart Campaign And New Drug Approvals

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel | Morningstar

Mitsubishi UFJ Trust & Banking Corp Decreases Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences reports new GTPase KRAS G12D inhibitors and degraders | BioWorld

M&T Bank Corp Sells 147,548 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Set to Acquire Arcellx

Imlunestrant with or without abemaciclib in advanced breast cancer: safety analyses from the EMBER-3 trial

Gilead Sciences Inc. (GILD): Growing Popularity as Defensive Stock

Top Pharmaceutical Stocks To Keep An Eye On - April 26th - Daily Political

Concurrent Investment Advisors LLC Grows Position in Gilead Sciences, Inc. $GILD

AEGON ASSET MANAGEMENT UK Plc Reduces Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Polaris Capital Management LLC

Arcus Biosciences (RCUS) Is Up 5.2% After Lung Trial Futility Results And Gilead Option Shift

Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks

Calamos Advisors LLC Sells 9,121 Shares of Gilead Sciences, Inc. $GILD

Gilead Refines Arcus Ties As Oncology Focus And Valuation Gap Draw Attention

2 Large-Cap Stocks to Consider Right Now and 1 We Turn Down

NBC Securities Inc. Acquires 10,296 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD is Kerusso Capital Management LLC's 6th Largest Position

Gilead Sciences, Inc. $GILD Stake Boosted by China Universal Asset Management Co. Ltd.

Kerusso Capital Management LLC Grows Stock Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Ends Losing Streak with 0.56% Gain

Has Gilead Sciences (GILD) Pulled Back Enough To Revisit Its Valuation Story?

Gilead Sciences, Inc. $GILD Holdings Decreased by Ruffer LLP

West Michigan Advisors LLC Purchases 4,173 Shares of Gilead Sciences, Inc. $GILD - Stock Observer

Assessing Gilead Sciences (GILD) Valuation After Recent Share Price Weakness And Long Term Gains

KLP Kapitalforvaltning AS Trims Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

Merck (MRK) Receives FDA Approval for Idvynso, a New HIV Treatment

Zacks Research Predicts Lower Earnings for Gilead Sciences

Ticino Wealth Buys Shares of 7,568 Gilead Sciences, Inc. $GILD - Daily Political

Population pharmacokinetics of tenofovir alafenamide delivered via an annual subdermal implant in South African women

Zurcher Kantonalbank Zurich Cantonalbank Purchases 19,741 Shares of Gilead Sciences, Inc. $GILD - Markets Daily

Gilead Sciences, Inc. $GILD Stake Lowered by Miller Howard Investments Inc. NY

Gilead Sciences, Inc. $GILD Shares Sold by Miller Howard Investments Inc. NY - Stock Observer

Gilead Deepens Oncology Reach And HIV Prevention With Arcellx And Lenacapavir

Gilead Sciences, Inc. $GILD Shares Acquired by AE Wealth Management LLC

Gilead Leans Further Into Oncology With Arcellx And Tubulis Deals

Gilead Sciences, Inc. $GILD Shares Bought by GF Fund Management CO. LTD.

Gilead Sciences, Inc. $GILD Position Raised by Asset Management One Co. Ltd.

The Goldman Sachs Group Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Stock Observer

Citi Raises Gilead (GILD) Price Target Ahead of Q1 Biopharma Preview

How Investors Are Reacting To Gilead Sciences (GILD) Expanding No‑Profit Lenacapavir Access Globally

Jim Cramer on Gilead Sciences: "I'd Hold On to It"

GILD: Oncology Deals And HIV Franchise Will Support Future Earnings

Gilead Sciences (NASDAQ:GILD) Given New $130.00 Price Target at The Goldman Sachs Group

Morgan Stanley Adjusts Gilead Sciences, Inc. (GILD) Outlook Ahead of Q1 Earnings

Pharmaceutical Stocks To Follow Now - April 17th - Stock Observer

Mirae Asset Global Investments Co. Ltd. Grows Stake in Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Insider Johanna Mercier Sells 3,000 Shares - Markets Daily

Pimco's Triumph in 2025: A Bold Bond Strategy Pays Off

Fed Independence on the Line? Political Influence in 2026

US Holiday Shopping Season: Record Online Sales Amid Economic Vulnerabilities

US Economic Outlook 2026: A Roubini Analysis

Fed's Divergent Votes: A Sign of Policy Uncertainty?

Trading wisdom: how can I improve myself as a trader?

Can you trade CFDs on crypto: platform to trade cryptocurrency CFDs

EQV stock price today: Is EQV Ventures a good investment?

How to start investing in dividend ETFs: 7 Dividend ETFs to Watch

TSLQ ETF price forecast: How to track TSLQ ETF prices?

Russia Reportedly Providing Intelligence Support to Iran Amidst Escalating Middle East Conflict

US Economic Signals: Inflation Concerns and Growth Challenges

Gold Market Analysis: Navigating Stability Amidst Escalating Geopolitical Tensions

Apple Slashes App Store Commissions in China for Developers

Geopolitical Tensions, Economic Crosscurrents, and Technological Advancements: A Forward-Looking Analysis

Aussie Dollar Sees Surge in Bullish Bets Ahead of Reserve Bank of Australia Rate Decision

India's Silver Demand Surge: New Loan Framework Boosts Market

ADP Employment Data and the Fed's Policy Path: A Closer Look